CVRx, Inc. (CVRX)
NASDAQ: CVRX · Real-Time Price · USD
6.08
-0.61 (-9.12%)
At close: Feb 11, 2026, 4:00 PM EST
6.10
+0.02 (0.33%)
After-hours: Feb 11, 2026, 7:57 PM EST
CVRx, Inc. Revenue
CVRx, Inc. had revenue of $14.69M in the quarter ending September 30, 2025, with 9.85% growth. This brings the company's revenue in the last twelve months to $55.97M, up 18.44% year-over-year. In the year 2024, CVRx, Inc. had annual revenue of $51.29M with 30.53% growth.
Revenue (ttm)
$55.97M
Revenue Growth
+18.44%
P/S Ratio
2.79
Revenue / Employee
$271,694
Employees
206
Market Cap
159.36M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 51.29M | 12.00M | 30.53% |
| Dec 31, 2023 | 39.30M | 16.83M | 74.89% |
| Dec 31, 2022 | 22.47M | 9.43M | 72.36% |
| Dec 31, 2021 | 13.04M | 6.98M | 115.36% |
| Dec 31, 2020 | 6.05M | -204.00K | -3.26% |
| Dec 31, 2019 | 6.26M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Inogen | 347.03M |
| Treace Medical Concepts | 218.88M |
| InfuSystem Holdings | 141.05M |
| LENSAR | 59.14M |
| Apyx Medical | 47.90M |
| SANUWAVE Health | 41.28M |
| TriSalus Life Sciences | 40.21M |
| Rapid Micro Biosystems | 30.52M |
CVRX News
- 13 days ago - CVRx to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call on February 12, 2026 - GlobeNewsWire
- 19 days ago - CVRx Kicks Off One Of The Largest Heart Device Trials In History - Benzinga
- 20 days ago - CVRx Announces Initiation of BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population - GlobeNewsWire
- 4 weeks ago - CVRx, Inc. (CVRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 4 weeks ago - CVRx Reports Preliminary Fourth Quarter and Fiscal Year 2025 Financial Results and Issues Fiscal 2026 Guidance - GlobeNewsWire
- 5 weeks ago - CVRx Announces Implementation of New Category I CPT Codes for Barostim Therapy - GlobeNewsWire
- 7 weeks ago - CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 3 months ago - CVRx to Participate at the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire